![](/images/graphics-bg.png)
Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice
المؤلفون المشاركون
Cantarini, Luca
Frediani, Bruno
Fabbroni, Marta
Pagano, Veronica Anna
Manganelli, Stefania
Galeazzi, Mauro
Costa, Luisa
Caso, Francesco
المصدر
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-07-07
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Objective.
The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients in clinical practice.
Methods.
Patients treated with adalimumab (ADA), etanercept (ETA), or infliximab (INF) were retrospectively included.
Treatment persistence rates were analyzed by means of a stepwise logistic regression.
Differences between therapy duration were assessed by means of an analysis of variance model (ANOVA), while a chi-square test was used to evaluate relationships between therapies and causes of treatment discontinuation and the administration of concomitant disease-modifying antirheumatic drugs (DMARDs) among therapies and types of disease considering completed courses of therapy versus courses that were discontinued.
Results.
268 patients received a total of 353 anti-TNF treatment courses (97 ADA, 180 ETA, and 76 INF).
Comparison among therapies showed significant difference regarding the treatment persistence rates due to the contrast between ETA and INF ( P = 0.0062 ).
We observed that 84.7% of patients were still responding after 6 months of follow-up.
Comparison among diseases showed that there were significant differences between PsA and AS ( P = 0.0073 ) and PsA and PsA with predominant axial involvement ( P = 0.0467 ) in terms of duration of the therapy, while there were no significant differences with regard to the persistence rate.
Conclusions.
In this cohort, anti-TNF-α therapy was associated with high drug persistence rates.
As in rheumatoid arthritis, switching to another anti-TNF-α agent can be an effective option when, during the treatment of AS or PsA, therapy is suspended because of inefficacy or an adverse event.
Combination therapy with DMARDs was associated with a better persistence rate.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Fabbroni, Marta& Cantarini, Luca& Caso, Francesco& Costa, Luisa& Pagano, Veronica Anna& Frediani, Bruno…[et al.]. 2014. Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice. Mediators of Inflammation،Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1043855
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Fabbroni, Marta…[et al.]. Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice. Mediators of Inflammation No. 2014 (2014), pp.1-7.
https://search.emarefa.net/detail/BIM-1043855
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Fabbroni, Marta& Cantarini, Luca& Caso, Francesco& Costa, Luisa& Pagano, Veronica Anna& Frediani, Bruno…[et al.]. Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice. Mediators of Inflammation. 2014. Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1043855
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1043855
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)